SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-015785
Filing Date
2023-04-28
Accepted
2023-04-28 16:08:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tals_2023_defa14a_v2.htm DEFA14A 20572
2 GRAPHIC img141940078_0.jpg GRAPHIC 1228576
3 GRAPHIC img141940078_1.jpg GRAPHIC 110226
  Complete submission text file 0000950170-23-015785.txt   1863822
Mailing Address 93 WORCESTER STREET WELLESLEY MA 02481
Business Address 570 PRESTON ST. SUITE 400 LOUISVILLE KY 40202 502-398-9250
Talaris Therapeutics, Inc. (Filer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40384 | Film No.: 23866071
SIC: 2836 Biological Products, (No Diagnostic Substances)